Your trusted destination for CME, CPD & Medical Education across the Middle East.
King Abdulaziz University Hospital
Dr. Salwa Ibrahim Hindawi is an internationally renowned professor of hematology, consultant hematologist, transfusion medicine authority, and healthcare quality pioneer who has devoted over three decades to advancing clinical hematology,patient blood management (PBM), transfusion safety, and hemoglobinopathy care across the Kingdom of Saudi Arabia and the broader Middle East. She earned her Bachelor of Medicine and Bachelor of Surgery (MBChB) degree with high distinction, followed by structured postgraduate residency training in internal medicine and clinical pathology. Driven to master the complex diagnostic, molecular, and logistical frameworks governing non-malignant blood disorders and blood banking, she completed advanced subspecialty fellowship training in the United Kingdom, earning Fellowship status with the Royal College of Pathologists (FRCPath) and the American College of Physicians (FACP).
Holding senior academic and clinical appointments, Dr. Hindawi serves as Professor of Hematology and Transfusion Medicine at King Abdulaziz University in Jeddah while directing blood transfusion services and specialized benign hematology clinics at King Abdulaziz University Hospital (KAUH). Her specialized clinical scope encompasses hereditary anemia syndromes (including sickle cell disease and thalassemia major), immune thrombocytopenia (ITP),coagulation factor deficiencies, patient blood management (PBM), apheresis procedures, and blood bank quality systems.
Throughout her distinguished career in healthcare leadership, Dr. Hindawi has been a primary force behind introducing national Patient Blood Management (PBM) programs across the Arabian Gulf. Recognizing that unnecessary blood transfusions increase patient morbidity and strain health system resources, she has spearheaded interdisciplinary hospital taskforces to establish evidence-based protocols that prioritize preoperative iron deficiency correction, cell salvage techniques, and restrictive transfusion thresholds in chronic anemia patients.
A landmark milestone of Dr. Hindawi’s executive leadership has been her transformative work in raising blood bank safety and accreditation standards across the Middle East. Under her technical direction, regional transfusion centers have implemented advanced nucleic acid testing (NAT), pathogen inactivation technologies, donor hemovigilance systems, and international quality accreditations (such as AABB and CAP), establishing benchmark transfusion safety standards across Saudi Arabia.
In addition to her clinical directorships and university chair duties, Dr. Hindawi is a passionate master teacher, academic mentor, and clinical supervisor. She actively trains hematology fellows, clinical pathology residents, and medical laboratory specialists at King Abdulaziz University and affiliated teaching hospitals, directing accredited continuous medical education (CME) seminars, transfusion safety masterclasses, and diagnostic laboratory workshops. Her instructional philosophy stresses rigorous diagnostic accuracy, strict adherence to international quality standards, and compassionate, patient-centered care.
Dr. Hindawi is an exceptionally prolific physician-scientist who has authored over 120 peer-reviewed scientific publications, book chapters, clinical practice guidelines, and national policy monographs in leading international medical journals, including Transfusion, Vox Sanguinis, Blood Transfusion, and Journal of Clinical Pathology. Her extensive research portfolio focuses on evaluating the genetic epidemiology of hemoglobinopathies in the Arabian Peninsula,assessing iron overload monitoring techniques (such as cardiac and liver T2* MRI), measuring hemovigilance outcomes,and analyzing public health policies for voluntary blood donation.
Beyond her university and hospital responsibilities, Dr. Hindawi actively serves on executive boards and expert advisory committees for prestigious international organizations, including the International Society of Blood Transfusion (ISBT),the World Health Organization (WHO) expert panel on blood safety, and regional Saudi health councils. She routinely represents the Middle East as a keynote speaker, course director, and panel chairperson at major global congresses,advocating for equitable access to safe blood products and standardized hematology care across developing nations.
At the International Classical Hematology Conference 2026 (ICCH 2026), Dr. Salwa Ibrahim Hindawi stands out as a core scientific keynote presenter, masterclass director, and scientific steering committee advisor. Connecting consultant hematologists, clinical pathologists, transfusion specialists, and public health strategists, she provides delegates with essential, evidence-based tools to optimize non-malignant blood disorder management, implement modern patient blood management frameworks, and elevate clinical transfusion safety nationwide and across the region.

MeetingMinds Experts
MeetingMinds Experts